235 related articles for article (PubMed ID: 31228250)
1. Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis.
Mücke MM; Mayer A; Kessel J; Mücke VT; Bon D; Schwarzkopf K; Rüschenbaum S; Queck A; Göttig S; Vermehren A; Weiler N; Welker MW; Reinheimer C; Hogardt M; Vermehren J; Herrmann E; Kempf VAJ; Zeuzem S; Lange CM
Clin Infect Dis; 2020 Apr; 70(9):1916-1924. PubMed ID: 31228250
[TBL] [Abstract][Full Text] [Related]
2. Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding.
Mücke VT; Peiffer KH; Kessel J; Schwarzkopf KM; Bojunga J; Zeuzem S; Finkelmeier F; Mücke MM
PLoS One; 2022; 17(5):e0268638. PubMed ID: 35609050
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms.
Ferstl PG; Müller M; Filmann N; Hogardt M; Kempf VA; Wichelhaus TA; Lange CM; Vermehren J; Zeuzem S; Reinheimer C; Waidmann O
Infect Drug Resist; 2018; 11():2047-2061. PubMed ID: 30464547
[TBL] [Abstract][Full Text] [Related]
4. Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.
Marciano S; Gutierrez-Acevedo MN; Barbero S; Del C Notari L; Agozino M; Fernandez JL; Anders MM; Grigera N; Antinucci F; Orozco Ganem OF; Murga MD; Perez D; Palazzo A; Martinez Rejtman L; Duarte IG; Vorobioff J; Trevizan V; Bulaty S; Bessone F; Valverde M; Elizondo M; Bosia JD; Borzi SM; Stieben TE; Masola A; Ferretti SE; Arufe D; Demirdjian E; Raffa MP; Peralta M; Fainboim HA; Vazquez CE; Ruiz P; Martínez JE; Heffner LA; Odzak A; Dirchwolf M; Smud A; Mendizabal M; Bellizzi C; Martinez A; Tomatis J; Bruno A; Ramos A; Pages J; Tevez S; Gadano AC; Giunta DH
Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):481-491. PubMed ID: 36820931
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Spontaneous Bacterial Peritonitis.
Salerno F; La Mura V
Dig Dis; 2015; 33(4):582-5. PubMed ID: 26159277
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in patients with spontaneous bacterial peritonitis utilizing first-line or alternative agents for secondary prophylaxis.
Collette K; Bethea A; Schadler A; Kelley JL
Am J Health Syst Pharm; 2023 Nov; 80(Suppl 4):S123-S129. PubMed ID: 36680798
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.
Marciano S; Dirchwolf M; Diaz JM; Bermudez C; Gutierrez-Acevedo MN; Barcán LA; Smud A; Giunta D; Gadano AC
Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):540-546. PubMed ID: 30557229
[TBL] [Abstract][Full Text] [Related]
8. Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.
Lutz P; Parcina M; Bekeredjian-Ding I; Nischalke HD; Nattermann J; Sauerbruch T; Hoerauf A; Strassburg CP; Spengler U
PLoS One; 2014; 9(4):e93909. PubMed ID: 24714550
[TBL] [Abstract][Full Text] [Related]
9. Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications.
Li H; Wieser A; Zhang J; Liss I; Markwardt D; Hornung R; Neumann-Cip AC; Mayerle J; Gerbes A; Steib CJ
Eur J Clin Invest; 2020 Feb; 50(2):e13198. PubMed ID: 31886517
[TBL] [Abstract][Full Text] [Related]
10. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis.
Alexopoulou A; Papadopoulos N; Eliopoulos DG; Alexaki A; Tsiriga A; Toutouza M; Pectasides D
Liver Int; 2013 Aug; 33(7):975-81. PubMed ID: 23522099
[TBL] [Abstract][Full Text] [Related]
11. Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
Ardolino E; Wang SS; Patwardhan VR
Dig Dis Sci; 2019 Aug; 64(8):2359-2367. PubMed ID: 30761472
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis.
Mücke MM; Mücke VT; Graf C; Schwarzkopf KM; Ferstl PG; Fernandez J; Zeuzem S; Trebicka J; Lange CM; Herrmann E
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00223. PubMed ID: 32955202
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis: Benefit or Risk?
Gonzalez SA
Am J Gastroenterol; 2019 Apr; 114(4):553-555. PubMed ID: 30920419
[TBL] [Abstract][Full Text] [Related]
15. ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial.
Crocombe D; Ahmed N; Balakrishnan I; Bordea E; Chau M; China L; Corless L; Danquah V; Dehbi HM; Dillon JF; Forrest EH; Freemantle N; Gear DP; Hollywood C; Hunter R; Jeyapalan T; Kallis Y; McPherson S; Munteanu I; Portal J; Richardson P; Ryder SD; Virk A; Wright G; O'Brien A
Trials; 2022 Sep; 23(1):812. PubMed ID: 36167573
[TBL] [Abstract][Full Text] [Related]
16. Impact of bacterial infections and spontaneous bacterial peritonitis prophylaxis on phage-bacterial dynamics in cirrhosis.
Bajaj JS; Rodriguez MP; Fagan A; McGeorge S; Sterling RK; Lee H; Luketic V; Fuchs M; Davis BC; Sikaroodi M; Gillevet PM
Hepatology; 2022 Dec; 76(6):1723-1734. PubMed ID: 35561076
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of cases of Spontaneous Bacterial Peritonitis in cirrhosis patients.
Santoiemma PP; Dakwar O; Angarone MP
PLoS One; 2020; 15(9):e0239470. PubMed ID: 32986728
[TBL] [Abstract][Full Text] [Related]
18. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
Prado V; Hernández-Tejero M; Mücke MM; Marco F; Gu W; Amoros A; Toapanta D; Reverter E; Peña-Ramirez C; Altenpeter L; Bassegoda O; Mezzano G; Aziz F; Juanola A; Rodríguez-Tajes S; Chamorro V; López D; Reyes M; Hogardt M; Kempf VAJ; Ferstl PG; Zeuzem S; Martínez JA; Vila J; Arroyo V; Trebicka J; Fernandez J
J Hepatol; 2022 May; 76(5):1079-1089. PubMed ID: 35074475
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
[TBL] [Abstract][Full Text] [Related]
20. Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis.
Saab S; Hernandez JC; Chi AC; Tong MJ
Am J Gastroenterol; 2009 Apr; 104(4):993-1001; quiz 1002. PubMed ID: 19277033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
